ArticleFrontiers in oncology2021

Targeting PI3K, FGFR, CDK4/6 Signaling Pathways Together With Cytostatics and Radiotherapy in Two Medulloblastoma Cell Lines.

Monika Lukoseviciute et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.